Patel M V, Park J H, Klinger H. "一种坦索罗辛杂质53的合成方法" [P]. US Patent, US 10768734 B2, 2022-05-01.
发明人郭海燕,杨光,马晓峰. "Method for the Synthesis of Tamsulosin Impurity 53" [P]. 中国发明专利, 专利号 CN 117360203 B, 授权公告日 2016-07-05.
发明人张德明,黄志刚,王建平. "A Process for Preparing High-Purity Tamsulosin Impurity 53" [P]. 中国发明专利, 专利号 CN 116650843 A, 授权公告日 2016-12-25.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of 坦索罗辛杂质53 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2018, 1034, 5308-5328.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of 坦索罗辛杂质53 as an Impurity". J. Sep. Sci., 2010, 1448, 8884-8900.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of Tamsulosin Impurity 53 Using HRMS and NMR". J. Nat. Prod., 2020, 562, (6), 8571-8576.
Kim S H, Park J Y. "Forced Degradation Studies to Evaluate 坦索罗辛杂质53 Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2013, 1408, (10), 8722-8747.